- Report
- February 2026
- 250 Pages
Global
From €4050EUR$4,490USD£3,472GBP
- Report
- October 2025
- 160 Pages
Global
From €2850EUR$3,160USD£2,444GBP
€3563EUR$3,950USD£3,055GBP
- Report
- September 2026
- 285 Pages
Global
From €5276EUR$5,850USD£4,524GBP
- Report
- May 2026
- 80 Pages
Global
From €5366EUR$5,950USD£4,601GBP
- Report
- June 2026
- 120 Pages
Global
From €5366EUR$5,950USD£4,601GBP
- Report
- June 2026
- 150 Pages
Global
From €5366EUR$5,950USD£4,601GBP
- Report
- September 2026
- 182 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 190 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 184 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 193 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 196 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- September 2026
- 190 Pages
Global
From €3197EUR$3,545USD£2,741GBP
€3553EUR$3,939USD£3,046GBP
- Report
- February 2026
- 250 Pages
Global
From €4050EUR$4,490USD£3,472GBP
- Report
- January 2026
- 250 Pages
Global
From €4050EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4050EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4050EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4050EUR$4,490USD£3,472GBP
- Report
- July 2026
- 180 Pages
Global
From €4284EUR$4,750USD£3,673GBP
- Report
- July 2026
- 120 Pages
Global
From €4284EUR$4,750USD£3,673GBP
- Report
- November 2025
- 150 Pages
Global
From €4374EUR$4,850USD£3,751GBP

The Oral Solid Dose (OSD) market is a segment of the drug delivery industry that focuses on the development and manufacture of solid dosage forms of drugs. OSD products are typically tablets, capsules, and powders that are taken orally. These products are designed to provide a convenient and efficient way to deliver drugs to the body. OSD products are often used to treat a variety of conditions, including chronic diseases, infections, and mental health disorders.
The OSD market is highly competitive, with many companies offering a wide range of products. Companies in the OSD market include Pfizer, GlaxoSmithKline, Novartis, Merck, and Sanofi. These companies are involved in the development, manufacture, and marketing of OSD products. Additionally, there are many smaller companies that specialize in the development and manufacture of OSD products. Show Less Read more